Fed. Circ. Refuses To Add Time To Intra-Cellular Patent Term
The Federal Circuit in a precedential opinion on Wednesday refused to tack an additional three weeks onto the life of an Intra-Cellular Therapies patent related to pharmaceutical salt crystals, finding that...To view the full article, register now.
Already a subscriber? Click here to view full article